Robert M. Plenge - 03 Jul 2023 Form 3 Insider Report for BRISTOL MYERS SQUIBB CO (BMY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
05 Jul 2023, 21:34:10 UTC
Prior SEC filing
14 Sep 2021
Next SEC filing
07 Aug 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lisa A. Atkins, attorney-in-fact for Robert M. Plenge

Key filing fact

Robert M. Plenge filed Form 3 for BRISTOL MYERS SQUIBB CO (BMY) on 05 Jul 2023.

Key facts

  • This page summarizes Robert M. Plenge's Form 3 filing for BRISTOL MYERS SQUIBB CO (BMY).
  • 0 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 05 Jul 2023, 21:34.

Change

  • Previous filing in this sequence was filed on 14 Sep 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMY holding

Common Stock, $0.10 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,316
Date
03 Jul 2023
Ownership
Direct
BMY holding

Common Stock, $0.10 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
200
Date
03 Jul 2023
Ownership
Family Trust
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BMY holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
16,375
Exercise price
$62.26
Footnotes
F2
BMY holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
616
Exercise price
Footnotes
F3, F4
BMY holding Derivative

Market Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
994
Exercise price
Footnotes
F5, F6
BMY holding Derivative

Market Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
2,329
Exercise price
Footnotes
F6, F7
BMY holding Derivative

Market Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
3,321
Exercise price
Footnotes
F8, F9
BMY holding Derivative

Market Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
9,368
Exercise price
Footnotes
F9, F10
BMY holding Derivative

Performance Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
6,985
Exercise price
Footnotes
F11
BMY holding Derivative

Performance Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
6,641
Exercise price
Footnotes
F12
BMY holding Derivative

Performance Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
03 Jul 2023
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
14,052
Exercise price
Footnotes
F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Shares held in a family trust, where reporting person is a beneficiary.

Footnote F2

All of the shares are currently exercisable. Pursuant to the Company's acquisition of Celgene Corporation, effective November 19, 2019, the stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement.

Footnote F3

These restricted stock units will vest on December 2, 2023.

Footnote F4

Each restricted stock unit converts into one share of common stock upon vesting.

Footnote F5

These market share units will vest on March 10, 2024.

Footnote F6

Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

Footnote F7

One-half of these market share units will vest on each of March 10, 2024 and March 10, 2025.

Footnote F8

One-third of these market share units will vest on each of March 10, 2024, March 10, 2025, and March 10, 2026.

Footnote F9

Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

Footnote F10

Twenty-five percent of these market share units will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 10, 2024.

Footnote F11

Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

Footnote F12

Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2025, subject to a Total Shareholder Return.

Footnote F13

Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026, subject to a Total Shareholder Return.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .